DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Landmesser U, Chapman MJ, Farnier M. et al.
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.
Eur Heart J 2017;
38: 2245-2255
Access:
We do not assume any responsibility for the contents of the web pages of other providers.